Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Bioentrepreneur
  • Published:

Building a curriculum for bioentrepreneurs

Nature Biotechnology volume 32, pages 863–865 (2014)Cite this article

Subjects

How best to educate scientists about the business of biotech?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Berret, D. Adjuncts are better teachers than tenured professors, study finds. Chron. Higher Educ. (9 September 2013).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lynn Johnson Langer is Director, Enterprise & Regulatory Science Programs, Center for Biotechnology Education, Advanced Academic Programs, The Johns Hopkins University, Rockville, Maryland, USA.,

    Lynn Johnson Langer

Authors
  1. Lynn Johnson Langer
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Lynn Johnson Langer.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Langer, L. Building a curriculum for bioentrepreneurs. Nat Biotechnol 32, 863–865 (2014). https://doi.org/10.1038/nbt.3012

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt.3012

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research